Immediate Impact
3 from Science/Nature 61 standout
Citing Papers
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
2024 Standout
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
Works of Karen Kimura being referenced
Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme Inhibition
2022
Evaluation of the Effects of Sodium–Glucose Co-Transporter 2 Inhibition with Empagliflozin on Morbidity and Mortality in Patients with Chronic Heart Failure and a Preserved Ejection Fraction: Rationale for and Design of the EMPEROR-Preserved Trial
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Karen Kimura | 119 | 98 | 21 | 161 | 131 | 43 | 534 | |
| I. Tyssebotn | 90 | 129 | 19 | 64 | 90 | 56 | 605 | |
| Yanting Chen | 53 | 30 | 15 | 203 | 132 | 38 | 524 | |
| Ágota Vér | 61 | 40 | 17 | 82 | 183 | 22 | 536 | |
| Takashi Iguchi | 87 | 173 | 23 | 127 | 60 | 26 | 512 | |
| Maria Fitzgibbon | 133 | 49 | 31 | 176 | 117 | 35 | 615 | |
| Rosa Aras‐López | 150 | 68 | 11 | 145 | 92 | 31 | 489 | |
| S. Nistrup Madsen | 159 | 55 | 21 | 289 | 113 | 36 | 627 | |
| Yukari Mimura | 83 | 62 | 42 | 226 | 202 | 41 | 597 | |
| Elżbieta Korobowicz | 90 | 139 | 105 | 43 | 136 | 28 | 571 | |
| Tomohiro Kamoda | 64 | 60 | 16 | 143 | 120 | 43 | 509 |
All Works
Loading papers...